QPW
VRPX

Quantum Private Wealth’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

Quantum Private Wealth’s Portfolio VRPX Stock Details VRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40
Closed -$10.8K – 189
2023
Q2 		$10.8K Hold
40
– – 0.01% 181
2023
Q1 		$7.85K Hold
40
– – ﹤0.01% 186
2022
Q4 		$6.22K Hold
40
– – ﹤0.01% 180
2022
Q3 		$11K Hold
40
– – 0.01% 182
2022
Q2 		$16K Buy
+40
New +$16.4K 0.01% 182
2022
Q1 		– Sell
-90
Closed -$77K – 214
2021
Q4 		$77K Buy
+90
New +$92.7K 0.03% 201

Other funds holding VRPX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantum Private Wealth's VRPX Position: Q3 2023 in Review

Quantum Private Wealth sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q3 2023, closing a stake of 40 shares — an estimated $10.8K sold.

Quantum Private Wealth first reported a position in VRPX in Q4 2021 and held it in 6 quarters. The position peaked at $77K in Q4 2021. 10 funds tracked by Wall St. Rank hold VRPX as of Q3 2023.

  • Quantum Private Wealth reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Quantum Private Wealth sold 40 Virpax Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $10.8K.
  • Quantum Private Wealth first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Quantum Private Wealth's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $77K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on Quantum Private Wealth's 13F filing for Q3 2023, filed 2 Nov 2023.